Pyrimidinones as Casein Kinase II (CK2) modulators
US8101625B2 · kind B2 · utility
1Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2006 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Jul 3, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.